Expression of p14ARF overcomes tumor resistance to p53

Cancer Research

Volumn 62, Issue 5, 2002, Pages 1305-1310

  Lu, Wenge ^a   Lin, Jiayuh ^b   Chen, Jiandong ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; PROTEIN MDM2; PROTEIN P53; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; GENE THERAPY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; TUMOR RESISTANCE; VIRAL GENE DELIVERY SYSTEM;

APOPTOSIS; GENE AMPLIFICATION; GENE THERAPY; GENES, P53; HUMANS; NEOPLASMS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036494469     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Database of p53 gene somatic mutations in human tumors and cell lines
2. Adenovirus-mediated Bax overexpression for the induction of therapeutic apoptosis in prostate cancer
3. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis
4. Mdm2: The ups and downs
5. The MDM2 gene amplification database
6. Tumor surveillance via the ARF-p53 pathway
7. Control of p53 ubiquitination and nuclear export by MDM2 and ARF
8. ARFparticipates in a regulatory feedback loop with p53 and MDM2
9. Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant d11520 (ONYX-015)
10. A modified p53 overcomes mdm2-mediated oncogenic transformation: A potential cancer therapeutic agent
11. Mapping of the p53 and mdm-2 interaction domains
12. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein
13. Ubiquitous induction of p53 in tumor cells by antisense inhibition of MDM2 expression
14. Several hydrophobic amino acids in the p53 N-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 EIB 55kd protein
15. Mutational analysis of p73 and p53 in human cancer cell lines
16. Cancer gene therapy mediated by CTS1, a p53 derivative: Advantage over wild-type p53 in growth inhibition of human tumors overexpressing MDM2
17. Genetic determinants of p53-induced apoptosis and growth arrest
18. Proliferation, cell cycle and apoptosis in cancer
19. Interaction between the retinoblastoma protein and the oncoprotein MDM2
20. ARFtumor suppressor
21. The loss of mdm2 induces p53-mediated apoptosis
22. Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment